Quantcast
Search Daily Dose & Film Annex
Loading

BIO SmartBrief

Daily Dose Newsletter

 
Fill out your e-mail address
to receive the DDE newsletter.
E-mail:
First:
Last:
 

Monday
Jan232012

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC)

See all Daily Dose articles on IMUC.

ImmunoCellular Therapeutics (OTCBB: IMUC) is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company is currently conducting a randomized, double-blinded, placebo controlled Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor associated antigens for glioblastoma in multiple centers in the United States.